EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation

Elena Gonzalez-Rodriguez, Delphine Stoll, Olivier Lamy iD

Case Reports in Rheumatology · 17.09.2018 · 2018 · 1-4

DOI: 10.1155/2018/5432751 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Rheumatology, erschienen am 17.09.2018. Verfasst von Elena Gonzalez-Rodriguez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Bone Diseases, CHUV, Lausanne University Hospital, Lausanne, Switzerland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At denosumab discontinuation, an antiresorptive agent is prescribed to reduce the high bone turnover, the rapid bone loss, and the risk of spontaneous vertebral fractures. We report the case of a woman treated with aromatase inhibitors and denosumab for 5 years. Raloxifene was then prescribed to prevent the rebound effect. Raloxifene was ineffective to reduce the high bone turnover and to avoid spontaneous clinical vertebral fractures. We believe that among the antiresorptive treatments, the most powerful bisphosphonates should be favored, and their administration adapted according to the serial follow-up of bone markers.

Autor:innen und Institutionen

  • Center of Bone Diseases, CHUV, Lausanne University Hospital, Lausanne, Switzerland.
  • Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.
  • Service of Internal Medicine, CHUV, Lausanne University Hospital, Lausanne, Switzerland.

ORCID-Profile: Olivier Lamy

Zitieren

APA

Gonzalez-Rodriguez, E., Stoll, D., & Lamy, O. (2018). Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation. Case Reports in Rheumatology, 2018, 1-4. https://doi.org/10.1155/2018/5432751

Vancouver

Gonzalez-Rodriguez E, Stoll D, Lamy O. Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation. Case Reports in Rheumatology. 2018;2018:1-4. doi:10.1155/2018/5432751

BibTeX
@article{GonzalezRodriguez2018,
  author = {Gonzalez-Rodriguez, Elena and Stoll, Delphine and Lamy, Olivier},
  title = {Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation},
  journal = {Case Reports in Rheumatology},
  year = {2018},
  volume = {2018},
  pages = {1--4},
  doi = {10.1155/2018/5432751}
}
Kostenlos starten →